Pharma and biotech companies routinely seek the opinion of leading academics and researchers, but interviewing thought leaders (more commonly known as Key Opinion Leaders or KOLs) is an art, rather than a science.
Tag Archives | breast cancer market research
One of the emerging trends we saw at the recent European Association of Urology (EAU) Congress in Paris was an increase in the number of plenary and session presentations by physicians from Eastern European countries. This trend is set to continue, and we expect to see more physicians from the BRIC (Brazil, Russia, India & […]
One of the pharma marketing strategy consulting services that we offer clients is a competitive landscape, market opportunity report. These custom reports analyze a pathway, disease, tumor type or competitive set, and can include a thorough analysis of clinical data, biomarkers, epidemiology, market size and competitor activity. All our work comes with actionable insights and […]
Sally Church on Pharma Strategy Blog discusses the issue of to what extent hormone replacement therapy (HRT) is linked to a higher incidence of breast cancer? Recent data published in the Journal of the American Medical Association (JAMA) showed a reduction in breast cancer incidence for those taking conjugate equine estrogens. This is in sharp […]
Nanotechnology is expected to provide major breakthroughs in how drugs cross the blood-brain barrier and reach into tumors. That promise is already starting to be seen. Research by Julia Ljubimova and her team at Cedars-Sinai Medical Center was recently published in the AACR journal, Cancer Research. They showed that biodegradable nanoparticles containing trastuzumab (herceptin), dramatically […]